|
TNFAIP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.248730E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.364300E-04 |
| Normal-vs-Stage2 |
5.35990000050113E-07 |
| Normal-vs-Stage3 |
1.185800E-04 |
| Normal-vs-Stage4 |
4.836300E-04 |
| Stage1-vs-Stage2 |
5.96520000000211E-05 |
| Stage1-vs-Stage3 |
3.707200E-01 |
| Stage1-vs-Stage4 |
6.934000E-01 |
| Stage2-vs-Stage3 |
1.864070E-03 |
| Stage2-vs-Stage4 |
2.059600E-02 |
| Stage3-vs-Stage4 |
7.999000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.954200E-04 |
| Normal-vs-AfricanAmerican |
2.602900E-03 |
| Normal-vs-Asian |
2.32909999999809E-05 |
| Caucasian-vs-AfricanAmerican |
8.848000E-01 |
| Caucasian-vs-Asian |
3.618200E-02 |
| AfricanAmerican-vs-Asian |
3.675000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.791100E-04 |
| Normal-vs-Female |
1.360360E-04 |
| Male-vs-Female |
9.077400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.619800E-04 |
| Normal-vs-Age(41-60Yrs) |
2.32919999999526E-05 |
| Normal-vs-Age(61-80Yrs) |
5.91899999999868E-05 |
| Normal-vs-Age(81-100Yrs) |
3.532200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.040400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.015160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.659800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.220800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.911050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.035800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.972200E-01 |
| Classical-VS-Follicular |
3.624600E-04 |
| Classical-VS-Other |
4.210200E-02 |
| Classical-VS-Normal |
4.849800E-04 |
| Tall-VS-Follicular |
5.983600E-02 |
| Tall-VS-Other |
1.244560E-01 |
| Tall-VS-Normal |
2.217200E-03 |
| Follicular-VS-Other |
9.525200E-01 |
| Follicular-VS-Normal |
2.05679999998321E-06 |
| Other-VS-Normal |
2.32589999999977E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.51360000000467E-05 |
| Normal-vs-N1 |
7.96100000000077E-05 |
| N0-vs-N1 |
8.191800E-01 |
|
|
